References
- Bairey Merz CN, Shaw LJ, Reis SE, et al. Insights from the NHLBI sponsored women’s ischemia syndrome evaluation (WISE) study: part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 2006;47:S21–S9
- Eaker ED, Chesebro JH, Sacks FM, Wenger NK, Whisnant JP, Winston M. Cardiovascular disease in women. Circulation 1993;88:1999–2009
- Novella S, Dantas AP, Segarra G, Medina P, Hermenegildo C. Vascular aging in women: is estrogen the fountain of youth? Front Physiol 2012;3:165
- Ruan X, Jin J, Hua L, Liu Y, Wang J, Liu S. The prevalence of metabolic syndrome in chinese postmenopausal women and the optimum body composition indices to predict it. Menopause 2010;17:566–70
- Royer M, Castelo-Branco C, Blumel JE. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women. Climacteric 2007;10:164–70
- Figueiredo Neto JA, Figueredo ED, Barbosa JB, et al. Metabolic syndrome and menopause: crosssectional study in gynecology clinic. Arq Bras Cardiol 2010;95:339–45
- Marjani A, Moghasemi S. The metabolic syndrome among Postmenopausal Women in Gorgan. Int J Endocrinol 2012;2012:953627
- Alibasic E, Ramic E, Bajraktarevic A, Ljuca F, Batic-Mujanovic O, Zildzic M. Atherogenic dyslipidemia and residual vascular risk in practice of family doctor. Med Arh 2015;69:339–41
- Anagnostis P, Stevenson JC, Crook D, Johnston DG, Godsland IF. Effects of gender, age and menopausal status on serum apolipoprotein concentrations. Clin Endocrinol 2016;85:733–40
- Fonseca MIH, Silva It d, Ferreira SRG. Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?. Diabetol Metab Syndr 2017;9:22
- Zhu L, Lu Z, Zhu L, et al. Lipoprotein ratios are better than conventional lipid parameters in predicting coronary heart disease in Chinese Han people. Kardiol Pol 2015; 73:931–8
- Kim SW, Jee JH, Kim HJ, et al. Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1. Int J Cardiol 2013;168:2678–83
- Nambi V, Chambless L, Folsom AR, et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) Study. J Am Coll Cardiol 2010;55:1600–7
- Masson W, Huerín M, Vitagliano L, et al. Estimation of cardiovascular risk and detection of subclinical carotid atheromatosis in middle-aged postmenopausal women. RAC 2013;81:322–8
- Gurka MJ, Vishnu A, Santen RJ, DeBoer MD. Progression of metabolic syndrome severity during the menopausal transition. J Am Heart Assoc 2016;5:pii: e003609
- Pu D, Tan R, Yu Q, Wu J. Metabolic syndrome in menopause and associated factors: a meta-analysis. Climacteric 2017;20:583–91
- Polotsky HN, Polotsky AJ. Metabolic implications of menopause. Semin Reprod Med 2010;28:426–34
- Liu H, Deng X, Peng Y, et al. Meta-analysis of serum non-high-density lipoprotein cholesterol and risk of coronary heart disease in the general population. Clin Chim Acta 2017;471:23–8
- Liao P, Zeng R, Zhao X, Guo L, Zhang M. Prognostic value of non-high-density lipoprotein cholesterol for mortality in patients with coronary heart disease: a systematic review and meta-analysis. Int J Cardiol 2017;227:950–5
- Parhofer KG. Increasing HDL-cholesterol and prevention of atherosclerosis: a critical perspective. Atheroscler Suppl 2015;18:109–11
- Katakami N, Kaneto H, Osonoi T, et al. Usefulness of lipoprotein ratios in assessing carotid atherosclerosis in Japanese type 2 diabetic patients. Atherosclerosis 2011;214:442–7
- Masson W, Siniawski D, Lobo M, Molinero G, Huerín M. Association between triglyceride/HDL cholesterol ratio and carotid atherosclerosis in postmenopausal middle-aged women. Endocrinol Nutr 2016;63:327–32
- Wang K, Shan S, Zheng H, Zhao X, Chen C, Liu C. Non-HDL-cholesterol to HDL-cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-HDL-cholesterol: a cohort study. Lipids Health Dis 2018;17:196
- Zuo PY, Chen XL, Liu YW, Zhang R, He XX, Liu CY. Non-HDL-cholesterol to HDL-cholesterol ratio as an independent risk factor for the development of chronic kidney disease. Nutr Metab Cardiovasc Dis 2015;25:582–7
- Wu TT, Gao Y, Zheng YY, Ma YT, Xie X. Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women. Lipids Health Dis 2018;17:197